Literature DB >> 25824045

miR-107 and miR-25 simultaneously target LATS2 and regulate proliferation and invasion of gastric adenocarcinoma (GAC) cells.

Mingjun Zhang1, Xiaolei Wang1, Wanhu Li2, Yongchun Cui3.   

Abstract

Although a series of oncogenes and tumor suppressors were identified in the pathological development of gastric adenocarcinoma (GAC), the underlying molecule mechanism were still not fully understood. The current study explored the expression profile of miR-107 and miR-25 in GAC patients and their downstream regulative network. qRT-PCR analysis was performed to quantify the expression of these two miRNAs in serum samples from both patients and healthy controls. Dual luciferase assay was conducted to verify their putative bindings with LATS2. MTT assay, cell cycle assay and transwell assay were performed to explore how miR-107 and miR-25 regulate proliferation and invasion of gastric cancer cells. Findings of this study demonstrated that total miR-107 or miR-25 expression might be overexpressed in gastric cancer patients and they can simultaneously and synchronically regulate LATS2 expression, thereby affecting gastric cancer cell growth and invasion. Therefore, the miR-25/miR-107-LATS2 axis might play an important role in proliferation and invasion of the gastric cancer cells.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Gastric adenocarcinoma; LATS2; miR-107; miR-25

Mesh:

Substances:

Year:  2015        PMID: 25824045     DOI: 10.1016/j.bbrc.2015.03.110

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  23 in total

1.  miR-335 directly, while miR-34a indirectly modulate survivin expression and regulate growth, apoptosis, and invasion of gastric cancer cells.

Authors:  Bairen Yang; Jun Huang; Hao Liu; Weichang Guo; Guoxin Li
Journal:  Tumour Biol       Date:  2015-08-29

2.  The clinical significance and biological function of large tumour suppressor 2 in hepatocellular carcinoma.

Authors:  Rong Liang; Yan Lin; Chun-Ling Yuan; Zhi-Hui Liu; Yong-Qiang Li; Xiao-Ling Luo; Jia-Zhou Ye; Hai-Hong Ye
Journal:  Cell Prolif       Date:  2017-03-01       Impact factor: 6.831

Review 3.  Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review.

Authors:  Ya-Kai Huang; Jian-Chun Yu
Journal:  World J Gastroenterol       Date:  2015-09-14       Impact factor: 5.742

4.  MiR-25 protects PC-12 cells from H2O2 mediated oxidative damage via WNT/β-catenin pathway.

Authors:  Yi Guo; Shizhen Niu
Journal:  J Spinal Cord Med       Date:  2017-06-12       Impact factor: 1.985

5.  Key Genes in Stomach Adenocarcinoma Identified via Network Analysis of RNA-Seq Data.

Authors:  Li Shen; Lizhi Zhao; Jiquan Tang; Zhiwei Wang; Weisong Bai; Feng Zhang; Shouli Wang; Weihua Li
Journal:  Pathol Oncol Res       Date:  2017-01-05       Impact factor: 3.201

6.  miR-25 promotes glioblastoma cell proliferation and invasion by directly targeting NEFL.

Authors:  Gang Peng; Xianrui Yuan; Jian Yuan; Qing Liu; Minhui Dai; Chenfu Shen; Jianrong Ma; Yiwei Liao; Weixi Jiang
Journal:  Mol Cell Biochem       Date:  2015-07-26       Impact factor: 3.396

Review 7.  The LATS1 and LATS2 tumor suppressors: beyond the Hippo pathway.

Authors:  Noa Furth; Yael Aylon
Journal:  Cell Death Differ       Date:  2017-06-23       Impact factor: 15.828

8.  MicroRNA-25 contributes to cisplatin resistance in gastric cancer cells by inhibiting forkhead box O3a.

Authors:  Jingbo He; Huixiong Qi; Fang Chen; Chuanhua Cao
Journal:  Oncol Lett       Date:  2017-09-18       Impact factor: 2.967

9.  MicroRNA-107 may regulate lung cancer cell proliferation and apoptosis by targeting TP53 regulated inhibitor of apoptosis 1.

Authors:  Peng Cai; Jingjing Li; Guiming Chen; Bing Peng; Liuyang Yu; Bolin Zhao; Yi Yu
Journal:  Oncol Lett       Date:  2020-01-07       Impact factor: 2.967

10.  MicroRNA-214 Mediates Isoproterenol-induced Proliferation and Collagen Synthesis in Cardiac Fibroblasts.

Authors:  Min Sun; Haiyi Yu; Youyi Zhang; Zijian Li; Wei Gao
Journal:  Sci Rep       Date:  2015-12-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.